Publication|Videos|August 30, 2024
DVCR is Designed Differently
Author(s)Dr. Vince Clinical Research
Advertisement
Zach Bader (Vice President, Business Development) talked with ACT about how Dr. Vince Clinical Research (DVCR) is changing the CRO industry.
Learn More About:
- How their new facility aides recruitment retention
- Their commitment to delivering quality data faster
- What a physician-run, physician-led CRO looks like
Additional Resources
Webinar
Missed our recent webinar, ’Accelerating Clinical & Drug Development Timelines with AI’? The recording is now available—discover how AI is transforming drug discovery now with industry leaders from Dr. Vince Clinical Research, Enveda Biosciences, and Clario. Watch it here!
Brochure
DVCR would like to serve as Your Full-Service CRO™. Explore how our team of experienced early clinical development professionals can support your research needs in our comprehensive brochure .
Video
DVCR is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas. Watch the following video for an overview of our world-class clinical pharmacology unit and CRO services.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Accelerate Inclusive Enrollment and Delivery with Lightship
February 19th 2025
- Harmonizing Data in Clinical Research
October 21st 2024
- Parexel’s FSP: Evolving With Your Needs Now and in the Future
October 3rd 2024
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
Latest NIMBLE Study Results Highlight Progress in gMG Research
3
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
4
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
5